In the search for new CFTR correctors, Sampson and colleagues employed differential scanning fluorimetry to identify the phenylhydrazone compound RDR1, which exhibited moderate activity in rescuing F508del CFTR function in both cell-based models and an F508del CF mouse model [160]. The gene discussed is CFTR; the disease is cystic fibrosis.